ACAD
31.936
+0.496
+1.5782%
AEMD
1.517
+0.097
+6.8380%
APRI
1.516
+0.036
+2.4392%
ARNA
21.12
+0.1
+0.48%
ATEC
1.916
-0.004
-0.208%
CNAT
5.22
+0.04
+0.77%
CRXM
0.172
0.00
0.00%
CYTX
0.318
-0.003
-0.837074%
DXCM
75.51
-0.4
-0.53%
GNMK
9.52
+0.08
+0.85%
HALO
12.1
0.00
0.00%
ILMN
192.78
-1.98
-1.02%
INNV
0.112
-0.005
-4.1026%
INO
5.615
+0.055
+0.989%
ISCO
1.2
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
127.415
-0.555
-0.434%
LPTN
2.93
-2.93
-100.00%
MBVX
0.481
-0.029
-5.6078%
MEIP
2.554
-0.026
-1.0116%
MNOV
5.08
+0.03
+0.59%
MRTX
5.025
-0.275
-5.189%
MSTX
0.13
-0.01
-5.28%
NBIX
52.11
-0.55
-1.04%
NUVA
63.71
-0.99
-1.53%
ONCS
0.93
-0.01
-1.0532%
ONVO
1.889
-0.061
-3.128%
OREX
2.38
+0.04
+1.71%
OTIC
20.275
-0.075
-0.369%
QDEL
33.205
-0.275
-0.8220%
RCPT
231.96
0.00
0.00%
RGLS
0.918
+0.058
+6.6860%
RMD
74.035
-0.515
-0.691%
SCIE
0
0.00
0.00%
SPHS
1.92
+0.03
+1.59%
SRNE
1.65
-0.05
-2.94%
TROV
0.834
-0.017
-1.9412%
VICL
2.33
-0.04
-1.69%
VOLC
18
0.00
0.00%
ZGNX
12.55
+0.1
+0.80%
ACAD
31.936
+0.496
+1.5782%
AEMD
1.517
+0.097
+6.8380%
APRI
1.516
+0.036
+2.4392%
ARNA
21.12
+0.1
+0.48%
ATEC
1.916
-0.004
-0.208%
CNAT
5.22
+0.04
+0.77%
CRXM
0.172
0.00
0.00%
CYTX
0.318
-0.003
-0.837074%
DXCM
75.51
-0.4
-0.53%
GNMK
9.52
+0.08
+0.85%
HALO
12.1
0.00
0.00%
ILMN
192.78
-1.98
-1.02%
INNV
0.112
-0.005
-4.1026%
INO
5.615
+0.055
+0.989%
ISCO
1.2
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
127.415
-0.555
-0.434%
LPTN
2.93
-2.93
-100.00%
MBVX
0.481
-0.029
-5.6078%
MEIP
2.554
-0.026
-1.0116%
MNOV
5.08
+0.03
+0.59%
MRTX
5.025
-0.275
-5.189%
MSTX
0.13
-0.01
-5.28%
NBIX
52.11
-0.55
-1.04%
NUVA
63.71
-0.99
-1.53%
ONCS
0.93
-0.01
-1.0532%
ONVO
1.889
-0.061
-3.128%
OREX
2.38
+0.04
+1.71%
OTIC
20.275
-0.075
-0.369%
QDEL
33.205
-0.275
-0.8220%
RCPT
231.96
0.00
0.00%
RGLS
0.918
+0.058
+6.6860%
RMD
74.035
-0.515
-0.691%
SCIE
0
0.00
0.00%
SPHS
1.92
+0.03
+1.59%
SRNE
1.65
-0.05
-2.94%
TROV
0.834
-0.017
-1.9412%
VICL
2.33
-0.04
-1.69%
VOLC
18
0.00
0.00%
ZGNX
12.55
+0.1
+0.80%
Home » Archive by Category

Xconomy

AACR Review: Biden Fired Up, Incyte Doubles Up, BMS Up And Down

April 6, 2017 – 9:52 am

The American Association for Cancer Research held its annual meeting this week in Washington, DC, a convenient venue for former Vice President Joe Biden to deliver a broadside against the Trump…

[[Click headline to continue reading.]]

Arivale and Scripps Leaders to Chat at April 19 Xconomy Forum

April 6, 2017 – 5:41 am

A little over two years ago, President Obama laid out his vision for one of the nation’s most ambitious medical research programs—an effort to amass genomic data from at least 1 million…

[[Click headline to continue reading.]]

Zavante Plans FDA Filing After Antibiotic Hits Clinical Trial Goals

April 5, 2017 – 8:26 pm

As bacteria develop resistance to older antibiotics, doctors are clamoring for new options that work on these drug- resistant strains. Zavante Therapeutics has been researching one drug as a possible…

[[Click headline to continue reading.]]

FDA Nominee Scott Gottlieb To Anti-Vaccine Crowd: Get Over It

April 5, 2017 – 11:55 am

In what passes for a short hearing these days in Washington, DC, the Trump White House’s pick to run the Food and Drug Administration, Scott Gottlieb, spent less than three hours fielding…

[[Click headline to continue reading.]]

Stealthy San Diego-based Viracta Steps Into Light with $18.5M

April 4, 2017 – 4:00 am

Viracta Therapeutics, a San Diego anti-cancer biotech that has been operating below the radar for nearly two years, is today disclosing an initial closing on what could amount to as much as $18.4…

[[Click headline to continue reading.]]

Angionetics Nears Key Gene Therapy Trial for Coronary Heart Disease

April 3, 2017 – 8:40 pm

Christopher Reinhard will tell you there is nothing unusual about the 20-plus years he’s spent getting an experimental heart therapy to late-stage clinical trials. “Very rarely will you get a short…

[[Click headline to continue reading.]]

How Battling New Epidemics Helps Fight Age-Old Killers

April 3, 2017 – 1:20 am

Washington state has reported nearly 300 cases of mumps this winter and experts predict this may be the state’s worst flu season in years, a stark reminder of how dangerous even familiar viruses can…

[[Click headline to continue reading.]]

Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More

March 31, 2017 – 2:45 am

As far as singular weeks go for biotech, this was a big one. Three highly anticipated drugs were approved. One is the first injectable medication for eczema. Another might help fend off the…

[[Click headline to continue reading.]]

Echo Raises $7.5M to Meet Big Orders for Hybrid Digital Microscope

March 30, 2017 – 12:56 pm

Echo, a San Diego startup that has developed a digital, all-in-one microscope, says today it has closed on $7.5 million in a Series A round led by San Francisco-based Dolby Family Ventures and…

[[Click headline to continue reading.]]

Mary Lou Jepsen, Moonshots, and the Human Impact of Innovation

March 29, 2017 – 7:19 am

As expressions go, “moonshot” has recently been gaining a lot of popularity in the media vernacular. Many folks assume that it arose with NASA’s Apollo 11 mission to the moon. But it’s a matter of…

[[Click headline to continue reading.]]